Bank of Stockton Acquires 236 Shares of Danaher Co. (NYSE:DHR)

Bank of Stockton raised its holdings in Danaher Co. (NYSE:DHR) by 3.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,498 shares of the conglomerate’s stock after acquiring an additional 236 shares during the quarter. Bank of Stockton’s holdings in Danaher were worth $1,721,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. AMF Tjanstepension AB bought a new position in Danaher in the third quarter worth approximately $5,923,000. Howard Capital Management Group LLC grew its position in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after buying an additional 48 shares in the last quarter. Foundations Investment Advisors LLC increased its stake in shares of Danaher by 5.3% during the third quarter. Foundations Investment Advisors LLC now owns 1,637 shares of the conglomerate’s stock valued at $455,000 after buying an additional 82 shares during the period. Private Advisor Group LLC raised its holdings in shares of Danaher by 5.6% in the third quarter. Private Advisor Group LLC now owns 45,631 shares of the conglomerate’s stock valued at $12,686,000 after acquiring an additional 2,431 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its stake in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after acquiring an additional 428,897 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $208.10 on Friday. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market cap of $150.31 billion, a PE ratio of 39.41, a price-to-earnings-growth ratio of 2.61 and a beta of 0.83. The company’s 50 day moving average is $227.21 and its 200 day moving average is $247.52.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm earned $2.09 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 20.45%.

Analyst Ratings Changes

Several equities research analysts have recently commented on DHR shares. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Wells Fargo & Company reduced their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Citigroup dropped their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. JPMorgan Chase & Co. decreased their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.